Metabolite profiling identifies markers of uremia

Journal of the American Society of Nephrology

Volumn 21, Issue 6, 2010, Pages 1041-1051

  Rhee, Eugene P ^a,b   Souza, Amanda ^b   Farrell, Laurie ^a   Pollak, Martin R ^c   Lewis, Gregory D ^a   Steele, David J R ^a   Thadhani, Ravi ^a   Clish, Clary B ^b   Greka, Anna ^a   Gerszten, Robert E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; 6 N,N' DIMETHYLARGININE; ATORVASTATIN; BIOGENIC AMINE; BIOLOGICAL MARKER; CREATININE; DICARBOXYLIC ACID; DILTIAZEM; DIMETHYLGLYCINE; FERRIC HYDROXIDE SUCROSE; HIPPURIC ACID; HOMOGENTISIC ACID; INDICAN; ISOCITRIC ACID; KYNURENIC ACID; KYNURENINE; LISINOPRIL; METHYLMALONIC ACID; METOPROLOL; MULTIVITAMIN; N(G),N(G) DIMETHYLARGININE; NEPHROCAPS; NUCLEOTIDE DERIVATIVE; OROTIC ACID; PHENOL DERIVATIVE; S ADENOSYLHOMOCYSTEINE; SORBITOL; SPHINGOMYELIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; XANTHOSINE;

ADULT; ARTICLE; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; FEMALE; GLYCOLYSIS; HEMODIALYSIS; HUMAN; KETOACIDOSIS; KIDNEY FAILURE; LIPOLYSIS; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; UREMIA;

EID: 77952979558     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009111132     Document Type: Article

References (55)

1. Nicholson JK, Wilson ID: Opinion: understanding "global" systems biology: Metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2: 668-676, 2003
2. Want EJ, Nordstrom A, Morita H, Siuzdak G: From exogenous to endogenous: The inevitable imprint of mass spectrometry in metabolomics. J Proteome Res 6: 459-468, 2007
3. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Ha AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy WS Jr, Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP: A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-326, 2009
4. Pietilainen KH, Sysi-Aho M, Rissanen A, Seppanen-Laakso T, Yki- Jarvinen H, Kaprio J, Oresic M: Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects - a monozygotic twin study. PLoS One 2: e218, 2007
5. Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, Carr SA, Thadhani R, Gerszten RE, Mootha VK: Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 4: 214, 2008
6. Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Haring HU, Schleicher ED, Xu G, Lehmann R: Changes of the plasma metabolome during an oral glucose tolerance test: Is there more than glucose to look at? Am J Physiol Endocrinol Metab 296: E384-E393, 2009
7. He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, Chen JL, Tian H, Ling L: Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429: 188-193, 2004
8. Toma I, Kang JJ, Sipos A, Vargas S, Bansal E, Hanner F, Meer E, Peti-Peterdi J: Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest 118: 2526-2534, 2008
9. Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H, Li Y: Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149: 4519-4526, 2008
10. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J: Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439: 484-489, 2006
11. Prinsen BH, de Sain-van der Velden MG, de Koning EJ, Koomans HA, Berger R, Rabelink TJ: Hypertriglyceridemia in patients with chronic renal failure: Possible mechanisms. Kidney Int Suppl: S121-S124, 2003 (Pubitemid 36513391)
12. Vaziri ND: Dyslipidemia of chronic renal failure: The nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290: F262-F272, 2006
13. Bergstrom J, Wang T, Lindholm B: Factors contributing to catabolism in end-stage renal disease patients. Miner Electrolyte Metab 24: 92-101, 1998
14. Lim VS, Kopple JD: Protein metabolism in patients with chronic renal failure: Role of uremia and dialysis. Kidney Int 58: 1-10, 2000
15. Raj DS, Sun Y, Tzamaloukas AH: Hypercatabolism in dialysis patients. Curr Opin Nephrol Hypertens 17: 589-594, 2008
16. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y: Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13: 1894-1900, 2002
17. Kopple JD: Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 24: 1002-1009, 1994 (Pubitemid 24380475)
18. Nishizawa Y, Shoji T, Emoto M, Koyama H, Tahara H, Fukumoto S, Inaba M, Ishimura E, Miki T: Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: Another form of metabolic syndrome. Semin Nephrol 24: 423-425, 2004
19. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 63: 1934-1943, 2003
20. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, Berriz GF, Roth FP, Gerszten RE: Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112: 3868-3875, 2005
21. Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M, Farrell L, Asnani A, Cyrille M, Ramanathan A, Shaham O, Berriz G, Lowry PA, Palacios IF, Tasan M, Roth FP, Min J, Baumgartner C, Keshishian H, Addona T, Mootha VK, Rosenzweig A, Carr SA, Fifer MA, Sabatine MS, Gerszten RE: Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 118: 3503-3512, 2008
22. Sebedio JL, Pujos-Guillot E, Ferrara M: Metabolomics in evaluation of glucose disorders. Curr Opin Clin Nutr Metab Care 12: 412-418, 2009
23. Graessler J, Schwudke D, Schwarz PE, Herzog R, Shevchenko A, Bornstein SR: Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS One 4: e6261, 2009
24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
25. Barth MC, Ahluwalia N, Anderson TJ, Hardy GJ, Sinha S, Alvarez- Cardona JA, Pruitt IE, Rhee EP, Colvin RA, Gerszten RE: Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J Biol Chem 284: 19189-19195, 2009
26. Sebekova K, Spustova V, Opatrny K Jr, Dzurik R: Serotonin and 5-hydroxyindole- acetic acid. Bratisl Lek Listy 102: 351-356, 2001
27. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G: Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 106: 3698-3703, 2009
28. Bain MA, Faull R, Fornasini G, Milne RW, Evans AM: Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant 21:1300-1304, 2006
29. Zhang AQ, Mitchell SC, Smith RL: Dietary precursors of trimethylamine in man: a pilot study. Food Chem Toxicol 37: 515-520, 1999
30. Causse E, Pradelles A, Dirat B, Negre-Salvayre A, Salvayre R, Couderc F: Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE. Electrophoresis 28: 381-387, 2007
31. Gregersen N, Mortensen PB, Kolvraa S: On the biologic origin of C6-C10-dicarboxylic and C6-C10-omega-1-hydroxy monocarboxylic acids in human and rat with acyl-CoA dehydrogenation deficiencies: In vitro studies on the omega- and omega-1-oxidation of medium-chain (C6-C12) fatty acids in human and rat liver. Pediatr Res 17: 828-834, 1983
32. Mortensen PB, Gregersen N: The biological origin of ketotic dicarboxylic aciduria. In vivo and in vitro investigations of the omegaoxidation of C6-C16-monocarboxylic acids in unstarved, starved and diabetic rats. Biochim Biophys Acta 666: 394-404, 1981
33. Mortensen PB: Formation and degradation of dicarboxylic acids in relation to alterations in fatty acid oxidation in rats. Biochim Biophys Acta 1124: 71-79, 1992
34. Mortensen PB, Gregersen N: The biological origin of ketotic dicarboxylic aciduria. II. In vivo and in vitro investigations of the beta-oxidation of C8-C16-dicarboxylic acids in unstarved, starved and diabetic rats. Biochim Biophys Acta 710: 477-484, 1982
35. Mortensen PB: The possible antiketogenic and gluconeogenic effect of the omega-oxidation of fatty acids in rats. Biochim Biophys Acta 620: 177-185, 1980 (Pubitemid 11216237)
36. Pettersen JE: Urinary excretion of n-hexanedioic and n-octanedioic acid in juvenile diabetics with ketonuria. Diabetes 23: 16-20, 1974
37. Pettersen JE, Jellum E, Eldjarn L: The occurrence of adipic and suberic acid in urine from ketotic patients. Clin Chim Acta 38: 17-24, 1972
38. Sim KG, Hammond J, Wilcken B: Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders. Clin Chim Acta 323: 37-58, 2002
39. Bjorkhem I, Blomstrand S, Haga P, Kase BF, Palonek E, Pedersen JI, Strandvik B, Wikstrom SA: Urinary excretion of dicarboxylic acids from patients with the Zellweger syndrome. Importance of peroxisomes in beta-oxidation of dicarboxylic acids. Biochim Biophys Acta 795: 15-19, 1984
40. Bohmer T, Bergrem H, Eiklid K: Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1: 126-128, 1978
41. Lim PS, Ma YS, Cheng YM, Chai H, Lee CF, Chen TL, Wei YH: Mitochondrial DNA mutations and oxidative damage in skeletal muscle of patients with chronic uremia. J Biomed Sci 9: 549-560, 2002 (Pubitemid 35316867)
42. Liu CS, Ko LY, Lim PS, Kao SH, Wei YH: Biomarkers of DNA damage in patients with end-stage renal disease: Mitochondrial DNA mutation in hair follicles. Nephrol Dial Transplant 16: 561-565, 2001
43. Rossato LB, Nunes AC, Pereira ML, de Souza CF, Dummer C, Milani V, Porsch DB, de Mattos CB, Barros EJ: Prevalence of 4977bp deletion in mitochondrial DNA from patients with chronic kidney disease receiving conservative treatment or hemodialysis in southern Brazil. Ren Fail 30: 9-14, 2008
44. Rao M, Li L, Demello C, Guo D, Jaber BL, Pereira BJ, Balakrishnan VS: Mitochondrial DNA injury and mortality in hemodialysis patients. J Am Soc Nephrol 20: 189-196, 2009
45. Gutman M: Modulation of mitochondrial succinate dehydrogenase activity, mechanism and function. Mol Cell Biochem 20: 41-60, 1978
46. Mirandola SR, Melo DR, Schuck PF, Ferreira GC, Wajner M, Castilho RF: Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J Inherit Metab Dis 31: 44-54, 2008
47. Pacanis A, Strzelecki T, Rogulski J: Effects of maleate on the content of CoA and its derivatives in rat kidney mitochondria. J Biol Chem 256: 13035-13038, 1981
48. Prichard SS: Impact of dyslipidemia in end-stage renal disease. J Am Soc Nephrol 14: S315-S320, 2003
49. Bohles H, Akcetin Z, Lehnert W: The influence of intravenous medium- and long-chain triglycerides and carnitine on the excretion of dicarboxylic acids. JPEN J Parenter Enteral Nutr 11: 46-48, 1987 (Pubitemid 17009516)
50. Brass EP, Tserng KY, Eckel RH: Urinary organic acid excretion during feeding of medium-chain or long-chain triglyceride diets in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 52: 923-926, 1990 (Pubitemid 20380814)
51. Raj DS, Welbourne T, Dominic EA, Waters D, Wolfe R, Ferrando A: Glutamine kinetics and protein turnover in end-stage renal disease. Am J Physiol Endocrinol Metab 288: E37-46, 2005
52. Ward RA, Shirlow MJ, Hayes JM, Chapman GV, Farrell PC: Protein catabolism during hemodialysis. Am J Clin Nutr 32: 2443-2449, 1979
53. Ikizler TA, Pupim LB, Brouillette JR, Levenhagen DK, Farmer K, Hakim RM, Flakoll PJ: Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab 282: E107-E116, 2002 (Pubitemid 34654113)
54. Nishikawa M, Ogawa Y, Yoshikawa N, Yoshimura M, Toyoda N, Shouzu A, Inada M: Plasma free thyroxine (FT4) concentrations during hemodialysis in patients with chronic renal failure: Effects of plasma non-esterified fatty acids on FT4 measurement. Endocr J 43: 487-493, 1996 (Pubitemid 26386555)
55. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B: Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89: 147-191, 2009